Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| classical monocyte | 10 studies | 23% ± 7% | |
| non-classical monocyte | 3 studies | 18% ± 3% | |
| myeloid cell | 3 studies | 24% ± 9% | |
| epithelial cell | 3 studies | 23% ± 3% | |
| GABAergic neuron | 3 studies | 21% ± 3% | |
| glutamatergic neuron | 3 studies | 28% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 20% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 690.47 | 180 / 180 | 100% | 11.28 | 430 / 430 |
| stomach | 100% | 910.83 | 359 / 359 | 100% | 17.58 | 286 / 286 |
| esophagus | 100% | 894.69 | 1444 / 1445 | 100% | 16.20 | 183 / 183 |
| breast | 100% | 966.06 | 459 / 459 | 100% | 23.86 | 1117 / 1118 |
| lung | 100% | 1252.35 | 577 / 578 | 100% | 15.00 | 1155 / 1155 |
| prostate | 100% | 977.67 | 245 / 245 | 100% | 20.72 | 501 / 502 |
| brain | 100% | 1313.97 | 2640 / 2642 | 100% | 22.43 | 704 / 705 |
| intestine | 100% | 940.52 | 966 / 966 | 99% | 18.17 | 524 / 527 |
| bladder | 100% | 772.90 | 21 / 21 | 99% | 15.72 | 501 / 504 |
| thymus | 100% | 987.31 | 653 / 653 | 99% | 14.12 | 600 / 605 |
| pancreas | 100% | 572.47 | 327 / 328 | 99% | 15.34 | 177 / 178 |
| liver | 100% | 1242.79 | 226 / 226 | 99% | 11.36 | 402 / 406 |
| uterus | 100% | 852.88 | 170 / 170 | 99% | 13.40 | 454 / 459 |
| kidney | 100% | 1027.54 | 89 / 89 | 99% | 12.07 | 889 / 901 |
| skin | 100% | 1450.58 | 1809 / 1809 | 98% | 15.95 | 461 / 472 |
| adrenal gland | 100% | 1086.40 | 258 / 258 | 97% | 15.56 | 224 / 230 |
| adipose | 100% | 1247.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1049.43 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 16.23 | 29 / 29 |
| spleen | 100% | 1230.97 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 13.69 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.21 | 1 / 1 |
| peripheral blood | 98% | 1164.51 | 907 / 929 | 0% | 0 | 0 / 0 |
| muscle | 97% | 480.72 | 775 / 803 | 0% | 0 | 0 / 0 |
| heart | 95% | 473.15 | 816 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 74% | 4.73 | 59 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
| GO_0034243 | Biological process | regulation of transcription elongation by RNA polymerase II |
| GO_0032783 | Cellular component | super elongation complex |
| GO_0015030 | Cellular component | Cajal body |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0016604 | Cellular component | nuclear body |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0008023 | Cellular component | transcription elongation factor complex |
| GO_0045171 | Cellular component | intercellular bridge |
| GO_0005515 | Molecular function | protein binding |
| GO_0003711 | Molecular function | transcription elongation factor activity |
| Gene name | EAF1 |
| Protein name | ELL associated factor 1 ELL-associated factor 1 |
| Synonyms | |
| Description | FUNCTION: Acts as a transcriptional transactivator of ELL and ELL2 elongation activities. . |
| Accessions | ENST00000396842.7 [Q96JC9-1] F8WFA5 ENST00000449565.1 Q96JC9 |
